Strong market share in multiple markets, rising margins, and dry powder for accretive deals makes CareFusion worth a closer look. CareFusion's infusion business has prospered in the wake of regulatory ...
Becton, Dickinson & Co.'s plans to spend $12.2 billion to acquire CareFusion emphasizes the rapid consolidation underway in the medical technology sector as manufacturers seek to offset pricing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback